Physician profile
Varun Roy
NPI 1811424559
$1,305.40
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $95.38 · 2021: $509 · 2022: $374 · 2023: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245 · Education: $81.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.38 |
| Education | $81.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $275.07 | 2020-2023 | |
| Abbvie INC. | $244.88 | 2020-2023 | Venclexta |
| Incyte Corporation | $233.02 | 2021-2023 | Jakafi |
| Celgene Corporation | $127.97 | 2021-2023 | Pomalyst |
| Astrazeneca Pharmaceuticals Lp | $117.43 | 2021 | |
| Amgen INC. | $115.26 | 2020-2023 | Kyprolis |
| Merck Sharp & Dohme LLC | $70.00 | 2022 | |
| Seagen INC. | $28.41 | 2023 | Tukysa |
| Pfizer INC. | $27.17 | 2022 | |
| Servier Pharmaceuticals LLC | $24.40 | 2023 | |
| Eisai INC. | $23.43 | 2022 | |
| Lilly USA, LLC | $18.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.